BGIM
Brandywine Global Investment Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58M | Sell |
1,510,384
-224
| -0% | -$8.6K | 0.41% | 62 |
|
|
2025
Q1 | $58.5M | Sell |
1,510,608
-87,389
| -5% | -$3.39M | 0.42% | 58 |
|
|
2024
Q4 | $54M | Sell |
1,597,997
-6,499
| -0.4% | -$220K | 0.39% | 67 |
|
|
2024
Q3 | $62.8M | Buy |
1,604,496
+4,645
| +0.3% | +$182K | 0.42% | 64 |
|
|
2024
Q2 | $61.6M | Sell |
1,599,851
-62,163
| -4% | -$2.39M | 0.46% | 52 |
|
|
2024
Q1 | $71.3M | Buy |
1,662,014
+95,903
| +6% | +$4.11M | 0.51% | 50 |
|
|
2023
Q4 | $58M | Buy |
1,566,111
+122,534
| +8% | +$4.54M | 0.47% | 56 |
|
|
2023
Q3 | $52.3M | Sell |
1,443,577
-53,115
| -4% | -$1.93M | 0.46% | 60 |
|
|
2023
Q2 | $53.3M | Buy |
1,496,692
+133,323
| +10% | +$4.75M | 0.44% | 64 |
|
|
2023
Q1 | $48.5M | Sell |
1,363,369
-56,501
| -4% | -$2.01M | 0.39% | 72 |
|
|
2022
Q4 | $49.9M | Buy |
1,419,870
+161,017
| +13% | +$5.66M | 0.39% | 74 |
|
|
2022
Q3 | $37M | Sell |
1,258,853
-50,712
| -4% | -$1.49M | 0.35% | 84 |
|
|
2022
Q2 | $57M | Sell |
1,309,565
-31,164
| -2% | -$1.36M | 0.5% | 54 |
|
|
2022
Q1 | $58.4M | Sell |
1,340,729
-38,719
| -3% | -$1.69M | 0.43% | 67 |
|
|
2021
Q4 | $60.8M | Buy |
1,379,448
+199,297
| +17% | +$8.79M | 0.43% | 59 |
|
|
2021
Q3 | $45.1M | Buy |
1,180,151
+178,364
| +18% | +$6.82M | 0.34% | 79 |
|
|
2021
Q2 | $39.9M | Buy |
1,001,787
+199,501
| +25% | +$7.94M | 0.3% | 78 |
|
|
2021
Q1 | $28.6M | Buy |
802,286
+54,765
| +7% | +$1.95M | 0.22% | 126 |
|
|
2020
Q4 | $27.5M | Buy |
+747,521
| New | +$27.5M | 0.23% | 117 |
|
|
2014
Q1 | – | Sell |
-1,271,871
| Closed | -$67.9M | – | 955 |
|
|
2013
Q4 | $67.9M | Sell |
1,271,871
-12,616
| -1% | -$674K | 0.62% | 40 |
|
|
2013
Q3 | $64.4M | Sell |
1,284,487
-20,354
| -2% | -$1.02M | 0.64% | 36 |
|
|
2013
Q2 | $65.2M | Buy |
+1,304,841
| New | +$65.2M | 0.67% | 32 |
|